Thalidomide Effects in Patients with Hereditary Hemorrhagic Telangiectasia During Therapeutic Treatment and in Fli-EGFP Transgenic Zebrafish Model

Thalidomide Effects in Patients with Hereditary Hemorrhagic Telangiectasia During Therapeutic Treatment and in Fli-EGFP Transgenic Zebrafish Model

Background: Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disease characterized by recurrent epistaxis, mucocutaneous telangiectasia, and arteriovenous malformations. The efficacy of traditional treatments for HHT is very limited. The aim of this study was to investigate the t...

Full description

Bibliographic Details
Main Authors: Hong-Ling Peng, Yi-Fang Yi, Shun-Ke Zhou, Si-Si Xie, Guang-Sen Zhang
Format: Article
Language:English
Published: Wolters Kluwer 2015-01-01
Series:Chinese Medical Journal
Subjects:
Hereditary Hemorrhagic Telangiectasia; Thalidomide; Zebrafish
Online Access:http://www.cmj.org/article.asp?issn=0366-6999;year=2015;volume=128;issue=22;spage=3050;epage=3054;aulast=Peng

Internet

http://www.cmj.org/article.asp?issn=0366-6999;year=2015;volume=128;issue=22;spage=3050;epage=3054;aulast=Peng

Similar Items